pocketful logo light
pocketful logo light
Ajanta Pharma Ltd logo

Ajanta Pharma Ltd

NSE: AJANTPHARM BSE: 532331

₹3563.60

(1.80%)

Sun, 27 Sept 2026, 11:12 pm

mtf coin illustrationMTF 5x

Ajanta Pharma Share Price Live Chart

1 Day

(1.80%)

No Result Found

Summary

  • Market Cap (in Cr)

    36358.77

  • Net Profit (in Cr)

    920.39

  • P/B

    8.66

  • Sector P/E

    33.76

  • P/E

    35.66

  • EV/EBITDA

    24.15

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    25.02

  • ROCE

    31.98

  • Debt/Equity

    0.01

  • EPS (TTM)

    84.52

  • Dividend Yield

    0

  • Book Value

    362.35

  • Interest Cover

    58.36

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters66.2566.2566.2566.2666.26
FII8.267.988.538.868.86
DII18.3718.5817.9017.5017.48
Public7.127.197.327.387.39
Government0.010.010.010.010.01

Read More

Technical Analysis

RSI

51.84

MACD

4.69

50 DMA

3525.99

200 DMA

3083.31

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic4386.133993.233797.573600.333404.673207.432814.53
Fibonacci3993.233843.153750.423600.333450.253357.523207.43
Camarilla3709.953673.933637.923600.333565.883529.873493.85

Pivots Level: Classic

R3

+785.80

4386.13

R2

+392.90

3993.23

R1

+197.23

3797.57

3600.33
3600.33
Pivot Point
LTP: 3547.80

S1

-195.67

3404.67

S2

-392.90

3207.43

S3

-785.80

2814.53

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    3538.90

  • 20-EMA

    3537.50

  • 30-EMA

    3529.13

  • 50-EMA

    3488.57

  • 100-EMA

    3356.18

  • 200-EMA

    3156.92

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
05 May 2026board-meetingsAccounts, Quarterly Results
30 Jan 2026board-meetingsQuarterly Results, Nine Months Results
03 Nov 2025dividend₹28.00 Dividend /Share10 Nov 2025
03 Nov 2025board-meetingsQuarterly Results, Half Yearly Results, Interim Dividend
10 Oct 2025dividendInterim Dividend - Rs. - 2810 Nov 2025
12 Jun 2025agm
28 Oct 2024dividend₹28.00 Dividend /Share06 Nov 2024
06 Oct 2024dividendInterim Dividend - Rs. - 2806 Nov 2024
14 Jun 2024agm
02 May 2024buyback

Read More

Peer Comparison

Ajanta Pharma Ltd logo

Ajanta Pharma Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Read More

Ajanta Pharma Ltd About

Ajanta Pharma is primarily involved in development, manufacturing and marketing of speciality pharmaceutical finished dosages.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1979

Headquarters

CEO

Mannalal B Agrawal

Employees

Contact

Website icon

Website

http://www.ajantapharma.com

Email icon

Email

info@ajantapharma.com; investorgrievance@ajantapha

Phone icon

Phone

91-22-66061000/1204/1203

Location icon

Location

Ajanta House, Charkop Kandivli (W), Mumbai, Maharashtra, 400067

Read More

Ajanta Pharma Ltd Company History

YearHistory
2020
  • Ajanta's 1st Sterile Eye Drop Production Unit was commissioned at the Guwahati Facility.
2021
  • Ajanta Pharma was listed in the Fortune 500 list of Indian companies, ranked 379th in Revenue Generation.
2022
  • The Company issued Bonus Shares in the Ratio of 1:2.
  • Ajanta Pharma was awarded India's Best Managed Companies for 2022 by Deloitte.
  • Ajanta won the Maharashtra State Best Employer Brand Awards 2022 in the Pharma sector.
  • Ajanta won Excellence in Packaging Developed in India and Packaging Team of the Year at India Packaging Awards 2022.
2023
  • The Company proposed a buyback of its equity shares.
  • Ajanta won the Outstanding Export Performance Award from Pharmexcil in the Formulation category.
  • Ajanta won the Excellence in Pharma Supply Chain Management award.
  • Ajanta won the Times Ascent Global Best Employer Brands 2023 award.
2024
  • Ajanta Pharma was certified as a great place to work in India for the 2nd year.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
MARSHALLWACEINVESTMENTSTRATEGIESMARKETNEUTRALTOPSFUNDblockBuy479012195.525 Jan 2024
SOCIETE GENERALEblockBuy1256172195.525 Jan 2024
MARSHALL WACE INVESTMENT STRATEGIESGTOPS FUNDblockBuy26852195.525 Jan 2024
BNP PARIBAS ARBITRAGEblockSell1256172195.525 Jan 2024
BNP PARIBAS ARBITRAGEblockSell505862195.525 Jan 2024
GRANDEUR PEAK EMERGING MARKETS OPPORTUNITIES FUNDblockSell1509421769.6520 Oct 2023
GRANDEUR PEAK GLOBAL TRUST GRANDEUR PEAK GLOBAL EXPLORER FUNDblockBuy8061769.6520 Oct 2023
GRANDEUR PEAK GLOBAL REACH FUNDblockSell156721769.6520 Oct 2023
GRANDEUR PEAK INTERNATIONAL STALWARTS FUNDblockSell3596791769.6520 Oct 2023
GRANDEUR PEAK GLOBAL TRUST GRANDEUR PEAK GLOBAL REACH FUNDblockBuy156721769.6520 Oct 2023

Read More

Ajanta Pharma Ltd News

Ajanta Pharma promoter releases pledge on 17 lakh shares

Aayush Agrawal, trustee of Aayush Agrawal Trust, released pledge on 17,36,353 Ajanta Pharma shares for loan repayment. The move reduces encumbered stake to 10.62% of total capital.

18 Sept 2026

companies

Ajanta Pharma Q1FY26: Profit up 31% YoY

Ajanta Pharma Ltd reports a 30.9% YoY rise in consolidated net profit to ₹334.22 crore for Q1FY26, driven by a 24.8% revenue increase to ₹1,625.96 crore.

31 Jul 2026

companies

Ajanta Pharma Q1FY27 Earnings Call Audio Released

Ajanta Pharma Ltd has uploaded the audio recording of its earnings call for the quarter ended June 30, 2026. The call was held on July 30, 2026, and a written transcript will follow.

30 Jul 2026

companies

Ajanta Pharma Q1 Results: Net Profit Jumps to ₹3.3B YoY

Ajanta Pharma posts Q1 consolidated net profit of 3.3B rupees vs 2.55B YoY, revenue rises to 16.3B rupees vs 13.03B YoY, while EBITDA margin narrows to 26.1% from 27%.

30 Jul 2026

companies

Ajanta Pharma to host Q1 FY27 earnings call

Ajanta Pharma will hold an earnings call on July 30, 2026, to discuss Q1 FY27 unaudited results. The leadership team will review financial performance.

20 Jul 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Ajanta Pharma Ltd?

    As of 28/09/2026 at 4:42 AM, Ajanta Pharma Ltd shares are trading at ₹3563.60.

  • 2.What is the market cap. of Ajanta Pharma Ltd?

    As of 28/09/2026, the market capitalization of Ajanta Pharma Ltd is ₹44,562.26 crore.

  • 3.When was Ajanta Pharma Ltd founded?

    Ajanta Pharma Ltd was founded in 1979.

  • 4.What are the P/E and P/B ratios of Ajanta Pharma Ltd?

    As of 28/09/2026, Ajanta Pharma Ltd has a P/E ratio of 39.25 and a P/B ratio of 8.66.

  • 5.How can I buy shares of Ajanta Pharma Ltd?

    You can buy shares of Ajanta Pharma Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Ajanta Pharma Ltd?

    As of March,2026, promoters hold 66.25% in Ajanta Pharma Ltd, while FIIs, DIIs and public shareholders hold 8.26%, 18.37% and 7.12%, respectively. The government holds 0.01%.

  • 7.Does Ajanta Pharma Ltd pay dividends?

    Yes, Ajanta Pharma Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹28.00 Dividend /Share per share.

  • 8.What is the dividend yield of Ajanta Pharma Ltd?

    As of 28 September, 2026, the dividend yield of Ajanta Pharma Ltd stands at 1.68%.

  • 9.What are the latest financial results of Ajanta Pharma Ltd?

    For January,2024, Ajanta Pharma Ltd reported revenue of ₹4,615.00 crore and a net profit of ₹920.00 crore.

  • 10.What is the Stock symbol of Ajanta Pharma Ltd?

    AJANTPHARM is the stock symbol of Ajanta Pharma Ltd.

  • 11.Who is the CEO of Ajanta Pharma Ltd?

    The CEO of Ajanta Pharma Ltd is Mannalal B Agrawal.